Aspira Pathlab Share Price | Aspira Pathlab Stock Screener
ASPIRA
Healthcare Service Provider
Share Price BSE
₹107.65
▲
2.10 (1.99%)
As of July 24, 2026, the Aspira Pathlab share price (BSE: ASPIRA) is ₹107.65, up 1.99% from the previous close, with shares trading between ₹105.55 and ₹107.65, and a 52-week range of ₹54.00–₹133.29.
Analyse ASPIRA stock price history and track historical price performance.
Use the Aspira Pathlab stock screener below to analyse P/E ratio, market cap, quarterly results, and more. Record your trades in TickJournal's free trading journal and track your portfolio performance.
Aspira Pathlab Market Cap
₹98.78 Cr.
ASPIRA P/E Ratio (TTM)
39.96
Aspira Pathlab P/B Ratio
13.24
EPS (TTM)
₹1.97
Dividend Yield
-
Debt to Equity
0.15
ASPIRA 52 Week High
₹133.29
Aspira Pathlab 52 Week Low
₹54.00
Operating Margin
13.00%
Profit Margin
-
ASPIRA Revenue (TTM)
₹5.00
EBITDA
₹1.00
Net Income
-
Total Assets
₹18.00
Total Equity
₹12.00
Aspira Pathlab Share Price Chart
Screen Aspira Pathlab share price with an interactive chart. Analyse ASPIRA price trends and volatility across different timeframes.
Aspira Pathlab Company Profile - Fundamental Screener
Screen Aspira Pathlab company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics
for ASPIRA shares.
Sector
Healthcare Services
Industry
Healthcare Service Provider
Sub-Sector
Healthcare Service Provider
Segment
E
ISIN
INE500C01017
Aspira Pathlab Balance Sheet Screener
Screen ASPIRA balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation
metrics.
| Item | 2025 | 2024 |
|---|---|---|
| Assets | ||
| Total Assets | 18 | 15 |
| Current Assets | 5 | 4 |
| Fixed Assets | 7 | 7 |
| Liabilities | ||
| Total Liabilities | 0 | 0 |
| Current Liabilities | 3 | 3 |
| Non-Current Liabilities | 0 | 0 |
| Shareholders' Equity | ||
| Total Equity | 12 | 10 |
| Share Capital | 10 | 10 |
| Reserves & Surplus | -3 | -5 |
Aspira Pathlab Income Statement Screener - Profit & Revenue Analysis
Screen Aspira Pathlab income statement and profit fundamentals.
Analyze ASPIRA quarterly results,
revenue growth, EBITDA, net profit margins, and EPS using TickJournal's fundamental screener for Aspira Pathlab share price evaluation.
| Item | 2025-Jun | 2025-Mar | 2024-Dec | 2024-Sept | 2024-Jun | 2024-Mar | 2023-Jun |
|---|---|---|---|---|---|---|---|
| Revenue | 5 | 6 | 6 | 6 | 5 | 4 | 3 |
| Expenses | 5 | 5 | 5 | 5 | 4 | 4 | 3 |
| EBITDA | 1 | 1 | 1 | 1 | 0 | 0 | 0 |
| Operating Profit % | 13.00% | 16.00% | 11.00% | 21.00% | 6.00% | -5.00% | -17.00% |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 0 | 1 | 0 | 1 | 0 | -1 | -1 |
| Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Profit | 0 | 1 | 0 | 1 | 0 | -1 | -1 |
| EPS | 0.41 | 0.66 | 0.30 | 0.96 | 0.05 | -0.49 | -0.70 |
Aspira Pathlab Cash Flow Screener - Liquidity Fundamentals
Screen ASPIRA cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price
strength assessment.
| Item | 2025-March | 2024-March |
|---|---|---|
| Operating Activities | 2 | 1 |
| Investing Activities | 0 | 0 |
| Financing Activities | -1 | -1 |
| Net Cash Flow | 1 | 0 |
Aspira Pathlab Shareholding Pattern Screener
See Aspira Pathlab shareholding pattern with promoter, FII, and DII holdings.
Check Aspira Pathlab promoter holding and ownership changes for ASPIRA on TickJournal.
| Item | 2026-Mar | 2025-Dec | 2025-Sept | 2025-Jun | 2025-Mar | 2024-Dec | 2024-Sept | 2024-Jun |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 18.39% | 18.39% | 18.39% | 18.39% | 18.39% | 18.55% | 18.55% | 18.72% |
| FII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| DII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 60.06% | 60.07% | 60.16% | 60.28% | 60.46% | 60.28% | 61.26% | 59.15% |
| Other Holding | 21.55% | 21.54% | 21.45% | 21.33% | 21.15% | 21.18% | 20.19% | 22.13% |
| Shareholder Count | 1,769 | 1,784 | 1,755 | 1,770 | 1,741 | 1,593 | 1,706 | 1,695 |
Aspira Pathlab Share Dividend Screener - Share Yield Analysis
Check Aspira Pathlab dividend history with payout and yield data.
View Aspira Pathlab dividend details including ex-dates and amounts for ASPIRA stock.
Aspira Pathlab Stock Index Membership
See which indices include Aspira Pathlab stock.
Check ASPIRA index membership in NIFTY 50, SENSEX, and other indices on TickJournal.
Aspira Pathlab Market Events Screener - Corporate Actions
Get Aspira Pathlab corporate actions including splits, bonuses, and buybacks.
Check Aspira Pathlab stock events that may affect ASPIRA share price.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| 2026-05-23 | 2026-05-23 | Quarterly Result Announcement | NA | 24.57% |
| 2026-02-10 | 2026-02-10 | Quarterly Result Announcement | NA | 13.68% |
| 2025-11-12 | 2025-11-12 | Quarterly Result Announcement | NA | -0.33% |
| 2025-09-26 | 2025-09-26 | Annual General Meeting | NA | -1.79% |
| 2025-08-12 | 2025-08-12 | Quarterly Result Announcement | NA | -6.20% |
| 2025-05-16 | 2025-05-16 | Quarterly Result Announcement | NA | -12.33% |
| 2025-02-07 | 2025-02-07 | Quarterly Result Announcement | NA | -9.00% |
| 2024-11-12 | 2024-11-12 | Quarterly Result Announcement | NA | 23.16% |
| 2024-09-27 | 2024-09-27 | Annual General Meeting | NA | 27.67% |
| 2016-11-16 | 2016-11-16 | Change Of Name | NA | - |
Aspira Pathlab Competitors Screener - Peer Comparison
Screen ASPIRA competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better
stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Dr. Lal Path Labs | 28,500 | 55.73 | 2,864 | 12.11% | 510 | 55.92 |
| Vijaya Diagnostic Centre | 13,699 | 79.34 | 814 | 16.36% | 182 | 48.41 |
| Metropolis Healthcare | 11,793 | 62.17 | 1,646 | 22.25% | 185 | 55.17 |
| Thyrocare Technologies | 8,959 | 54.28 | 846 | 20.48% | 163 | 59.90 |
| Nephrocare Health Services | 6,286 | 82.61 | 999 | 29.74% | 62 | 39.12 |
| Krsnaa Diagnostics | 1,792 | 17.41 | 773 | 4.05% | 106 | 51.75 |
| Suraksha Diagnostic | 1,359 | 42.71 | 310 | 21.30% | 34 | 41.17 |
| One Global Service Provider | 1,182 | 16.75 | 498 | 237.06% | 69 | 48.61 |
| 3B BlackBio DX | 1,092 | 18.00 | 142 | 27.17% | 61 | 58.62 |
| Health X Platform | 1,012 | -707.89 | 1,319 | 12.68% | -3 | 50.95 |
Aspira Pathlab Company Announcements - News Screener
Screen ASPIRA latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2026-07-18 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | - |
| 2026-06-24 | Closure of Trading Window | - |
| 2026-06-11 | Disclosure Under Regulation 30(LODR) For Classification Of Mr. Nikunj Mange And Mr. Jay Arvind Bhanushali As Promoters Of The Company | - |
| 2026-06-11 | Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 | - |
| 2026-06-11 | Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 | - |
| 2026-06-11 | Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 | - |
| 2026-06-10 | Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 | - |
| 2026-06-10 | Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 | - |
| 2026-05-25 | Compliances-Reg.24(A)-Annual Secretarial Compliance | - |
| 2026-05-25 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-05-23 | Announcement under Regulation 30 (LODR)-Change in Directorate | - |
| 2026-05-23 | Appointment of Company Secretary and Compliance Officer | - |
| 2026-05-23 | Announcement under Regulation 30 (LODR)-Change in Management Control | - |
| 2026-05-23 | Appointment Of M/S. Vishal J Bhanushali & Associates Practicing Chartered Accountant (Firm Registration Number: 145806W) Having Membership No. 179979 As An Internal Auditor Of The Company For The Financial Year 2026-2027. | - |
| 2026-05-23 | Integrated Financial Results As On March 31 2026 | - |
| 2026-05-23 | Board Meeting Outcome For Outcome Of The Board Meeting Dated May 23 2026 | - |
| 2026-05-23 | Board Meeting Outcome for Outcome Of The Board Meeting Dated May 23 2026 | - |
| 2026-05-18 | Board Meeting Intimation for Approval Of Audited Standalone Financial Results Of The Company Along With The Auditor Report As On March 31 2026 | - |
| 2026-05-18 | Post-Offer Advertisement | - |
| 2026-04-15 | Format of the Annual Disclosure to be made by an entity identified as a LC - Annexure B2 | - |